Furthermore, the mechanisms underpinning loss of Nuc-pYStat5a/b in breast cancer remain to be identified, and it is unknown whether reduced Nuc-pYStat5a/b levels in breast cancer may in part reflect reduced levels of Stat5a and/or Stat5b protein expression. The gene discussed is NUCB1; the disease is breast carcinoma.